{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:46Z","timestamp":1766023006402,"version":"3.48.0"},"reference-count":28,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/dbnd9679","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:52:52Z","timestamp":1753941172000},"page":"3063-3078","source":"Crossref","is-referenced-by-count":0,"title":["Comparative safety and efficacy of single-agent chemotherapy combined with microwave ablation versus radioactive seed brachytherapy in elderly patients with advanced NSCLC: a ten-year retrospective study"],"prefix":"10.62347","volume":"15","author":[{"given":"Wanying","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1384906","DOI":"10.3389\/fonc.2024.1384906","article-title":"Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer","volume":"14","author":"Chen","year":"2024","unstructured":"Chen Q, Ying S, Qin J and Zhang L. Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer. Front Oncol 2024; 14: 1384906.","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3390\/ijms26052120","article-title":"Immunotherapy for elderly patients with advanced non-small cell lung cancer: challenges and perspectives","volume":"26","author":"Baladi","year":"2025","unstructured":"Baladi A, Tafenzi HA, Zouiten O, Afani L, Essaadi I, El Fadli M and Belbaraka R. Immunotherapy for elderly patients with advanced non-small cell lung cancer: challenges and perspectives. Int J Mol Sci 2025; 26: 2120.","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Verschueren MV, Peters BJ, Bloem LT, Kruik VR, Uitvlugt EB, Bijsmans AR, Egberts AC and van de Garde EM. Pembrolizumab plus chemotherapy per PD-L1 stratum in patients with metastatic non-small cell lung cancer: real-world effectiveness versus trial efficacy. Clin Lung Cancer 2024; 25: 119-127, e1.","DOI":"10.1016\/j.cllc.2023.12.011"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.21037\/tlcr-20-1239","article-title":"Immune checkpoint inhibitors in elderly patients treated for a lung cancer: a narrative review","volume":"10","author":"Naltet","year":"2021","unstructured":"Naltet C and Besse B. Immune checkpoint inhibitors in elderly patients treated for a lung cancer: a narrative review. Transl Lung Cancer Res 2021; 10: 3014-3028.","journal-title":"Transl Lung Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1200\/JCO.2014.55.8627","article-title":"Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803\/WJOG4307L","volume":"33","author":"Abe","year":"2015","unstructured":"Abe T, Takeda K, Ohe Y, Kudoh S, Ichinose Y, Okamoto H, Yamamoto N, Yoshioka H, Minato K, Sawa T, Iwamoto Y, Saka H, Mizusawa J, Shibata T, Nakamura S, Ando M, Yokoyama A, Nakagawa K, Saijo N and Tamura T. Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803\/WJOG4307L. J Clin Oncol 2015; 33: 575-581.","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s40266-020-00785-8","article-title":"Platinum-based chemotherapy in older patients with non-small cell lung cancer: what to expect in the real world","volume":"37","author":"Pelizzari","year":"2020","unstructured":"Pelizzari G, Cortiula F, Giavarra M, Bartoletti M, Lisanti C, Buoro V, Cattaneo M, Rossetto C, Rizzato S, Puglisi F, Macerelli M, Fasola G and Follador A. Platinum-based chemotherapy in older patients with non-small cell lung cancer: what to expect in the real world. Drugs Aging 2020; 37: 677-689.","journal-title":"Drugs Aging"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1200\/OP.23.00263","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline questions and answers","volume":"19","author":"Williams","year":"2023","unstructured":"Williams GR, Hopkins JO, Klepin HD, Lowenstein LM, Mackenzie A, Mohile SG, Somerfield MR and Dale W. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline questions and answers. JCO Oncol Pract 2023; 19: 718-723.","journal-title":"JCO Oncol Pract"},{"key":"ref8","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: non-small cell lung cancer (Version 1.2024). NCCN 2024. Retrieved from https:\/\/www.nccn.org."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.4103\/jcrt.jcrt_880_22","article-title":"Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition)","volume":"18","author":"Ye","year":"2022","unstructured":"Ye X, Fan W, Wang Z, Wang J, Wang H, Niu L, Fang Y, Gu S, Liu L, Liu B, Zhuang Y, Wei Z, Li X, Li X, Li Y, Li C, Yang X, Yang W, Yang P, Lin Z, Meng Z, Hu K, Liu C, Huang Y, Huang G, Huang K, Peng Z, Han Y, Jin Y, Lei G, Zhai B, Li H, Pan J, Filippiadis D, Kelekis A, Pua U, Futacsi B, Yumchinserchin N, Iezzi R, Tang A and Roy SH. Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition). J Cancer Res Ther 2022; 18: 1213-1230.","journal-title":"J Cancer Res Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1007\/s00330-019-06613-x","article-title":"Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial","volume":"30","author":"Wei","year":"2020","unstructured":"Wei Z, Yang X, Ye X, Feng Q, Xu Y, Zhang L, Sun W, Dong Y, Meng Q, Li T, Wang C, Li G, Zhang K, Li P, Bi J, Xue G, Sun Y, Sheng L, Liu B, Yu G, Ren H, Wang J, Sun L, Chen S, Geng D, Zhang B, Xu X, Zhang L, Sun D, Xu X, Diao C, Huang G, Li W, Han X, Wang J, Meng M, Ni Y, Zheng A, Fan W, Li Y, Li F, Fan H, Zou Z, Li Q and Tian H. Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial. Eur Radiol 2020; 30: 2692-2702.","journal-title":"Eur Radiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12032-014-0395-8","article-title":"Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III\/IV non-small cell lung cancer versus the conventional radiotherapy","volume":"32","author":"Li","year":"2015","unstructured":"Li W, Guan J, Yang L, Zheng X, Yu Y and Jiang J. Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III\/IV non-small cell lung cancer versus the conventional radiotherapy. Med Oncol 2015; 32: 395.","journal-title":"Med Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.lungcan.2020.06.010","article-title":"Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy","volume":"146","author":"Chen","year":"2020","unstructured":"Chen C, Wang W, Yu Z, Tian S, Li Y and Wang Y. Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy. Lung Cancer 2020; 146: 290-296.","journal-title":"Lung Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"10581","DOI":"10.2147\/OTT.S272898","article-title":"125I seed brachytherapy combined with single-agent chemotherapy in the treatment of non-small-cell lung cancer in the elderly: a valuable solution","volume":"13","author":"Yue","year":"2020","unstructured":"Yue TH and Xing W. 125I seed brachytherapy combined with single-agent chemotherapy in the treatment of non-small-cell lung cancer in the elderly: a valuable solution. Onco Targets Ther 2020; 13: 10581-10591.","journal-title":"Onco Targets Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12032-014-0464-z","article-title":"Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone","volume":"32","author":"Wei","year":"2015","unstructured":"Wei Z, Ye X, Yang X, Huang G, Li W, Wang J and Han X. Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone. Med Oncol 2015; 32: 464.","journal-title":"Med Oncol"},{"key":"ref15","unstructured":"Ji Z, Ni Y, He C, Huo B, Liu S, Ma Y, Song Y, Hu M, Zhang K, Wang Z, Zhao X, Han H, Wang Y, Wang R, Chai S, Hu X, Huang X, Ye X and Wang J. Clinical outcomes of radioactive seed brachytherapy and microwave ablation in inoperable stage I non-small cell lung cancer. Am J Cancer Res 2023; 13: 3753-3762."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","unstructured":"Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Bhatia S, Katheria V, Klapper S, Hansen K, Ramani R, Lachs M, Wong FL and Tew WP. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011; 29: 3457-3465.","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1007\/s00330-020-07634-7","article-title":"Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis","volume":"31","author":"Chan","year":"2021","unstructured":"Chan MV, Huo YR, Cao C and Ridley L. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Eur Radiol 2021; 31: 5421-5433.","journal-title":"Eur Radiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.jvir.2019.11.035","article-title":"Survival outcomes of treatment with radiofrequency ablation, stereotactic body radiotherapy, or sublobar resection for patients with clinical stage I non-small-cell lung cancer: a single-center evaluation","volume":"31","author":"Iguchi","year":"2020","unstructured":"Iguchi T, Hiraki T, Matsui Y, Mitsuhashi T, Katayama N, Katsui K, Soh J, Sakurai J, Gobara H, Toyooka S and Kanazawa S. Survival outcomes of treatment with radiofrequency ablation, stereotactic body radiotherapy, or sublobar resection for patients with clinical stage I non-small-cell lung cancer: a single-center evaluation. J Vasc Interv Radiol 2020; 31: 1044-1051.","journal-title":"J Vasc Interv Radiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.jvir.2023.06.014","article-title":"Microwave ablation for inoperable stage I non-small cell lung cancer in patients aged &#x2265;70 years: a prospective, single-center study","volume":"34","author":"Peng","year":"2023","unstructured":"Peng JZ, Wang CE, Bie ZX, Li YM and Li XG. Microwave ablation for inoperable stage I non-small cell lung cancer in patients aged &#x2265;70 years: a prospective, single-center study. J Vasc Interv Radiol 2023; 34: 1771-1776.","journal-title":"J Vasc Interv Radiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/cbr.2020.3859","article-title":"A clinical study on microwave ablation in combination with chemotherapy in treating peripheral IIIB-IV non-small cell lung cancer","volume":"37","author":"Zhang","year":"2022","unstructured":"Zhang YQ, Wu YL, Feng Y and Zhou YX. A clinical study on microwave ablation in combination with chemotherapy in treating peripheral IIIB-IV non-small cell lung cancer. Cancer Biother Radiopharm 2022; 37: 141-146.","journal-title":"Cancer Biother Radiopharm"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13244-021-00997-5","article-title":"Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art","volume":"12","author":"P&#xE1","year":"2021","unstructured":"P&#xE1;ez-Carpio A, G&#xF3;mez FM, Isus Oliv&#xE9; G, Paredes P, Baetens T, Carrero E, S&#xE1;nchez M and Vollmer I. Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art. Insights Imaging 2021; 12: 57.","journal-title":"Insights Imaging"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00270-020-02432-6","article-title":"CIRSE standards of practice on thermal ablation of primary and secondary lung tumours","volume":"43","author":"Venturini","year":"2020","unstructured":"Venturini M, Cariati M, Marra P, Masala S, Pereira PL and Carrafiello G. CIRSE standards of practice on thermal ablation of primary and secondary lung tumours. Cardiovasc Intervent Radiol 2020; 43: 667-683.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"100844","DOI":"10.1016\/j.ctarc.2024.100844","article-title":"A review of the efficacy and safety of iodine-125 seed implantation for lung cancer treatment","volume":"41","author":"Li","year":"2024","unstructured":"Li Z, Hu Z, Xiong X and Song X. A review of the efficacy and safety of iodine-125 seed implantation for lung cancer treatment. Cancer Treat Res Commun 2024; 41: 100844.","journal-title":"Cancer Treat Res Commun"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.21037\/jtd.2017.03.14","article-title":"Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation","volume":"9","author":"Zhong","year":"2017","unstructured":"Zhong L, Sun S, Shi J, Cao F, Han X, Bao X and You Q. Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation. J Thorac Dis 2017; 9: 590-597.","journal-title":"J Thorac Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3892\/ol.2019.10375","article-title":"Usefulness of percutaneous microwave ablation for large non-small cell lung cancer: a preliminary report","volume":"18","author":"Pusceddu","year":"2019","unstructured":"Pusceddu C, Melis L, Sotgia B, Guerzoni D, Porcu A and Fancellu A. Usefulness of percutaneous microwave ablation for large non-small cell lung cancer: a preliminary report. Oncol Lett 2019; 18: 659-666.","journal-title":"Oncol Lett"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.4103\/jcrt.JCRT_1096_20","article-title":"Chinese expert consensus workshop report: guideline for permanent iodine-125 seeds implantation of primary and metastatic lung tumors (2020 edition)","volume":"16","author":"Zhang","year":"2020","unstructured":"Zhang F, Wang J, Guo J, Huang X, Guan Z, Lei G, Wang J, Ye X, Zhao X, Wang J, Wang R, Liu B, Zhou Q, Zhao M, Wang C and Li Y. Chinese expert consensus workshop report: guideline for permanent iodine-125 seeds implantation of primary and metastatic lung tumors (2020 edition). J Cancer Res Ther 2020; 16: 1549-1554.","journal-title":"J Cancer Res Ther"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/geriatrics9040101","article-title":"Lung cancer: new directions in senior patients assessment","volume":"9","author":"P&#xEE","year":"2024","unstructured":"P&#xEE;slaru AI, Albisteanu SM, Ilie AC, Stefaniu R, M&#xE2;rza A, Moscaliuc S, Nicoar&#x103; M, Turcu AM, Grigoras G and Alexa ID. Lung cancer: new directions in senior patients assessment. Geriatrics (Basel) 2024; 9: 101.","journal-title":"Geriatrics (Basel)"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/7\/ajcr0162741.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:51:55Z","timestamp":1766022715000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/7\/ajcr0162741.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/dbnd9679","relation":{},"ISSN":["2156-6976"],"issn-type":[{"type":"electronic","value":"2156-6976"}],"subject":[],"published":{"date-parts":[[2025]]}}}